vs
Side-by-side financial comparison of Ameren (AEE) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Ameren is the larger business by last-quarter revenue ($1.8B vs $1.1B, roughly 1.6× PERRIGO Co plc). Ameren runs the higher net margin — 14.2% vs -127.8%, a 142.0% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -8.2%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-54.0M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -0.9%).
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. It operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. The company engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution and transmission businesses. It primarily generates electricity through coal, nucle...
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AEE vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.1B |
| Net Profit | $253.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 20.2% | -116.0% |
| Net Margin | 14.2% | -127.8% |
| Revenue YoY | -8.2% | -2.5% |
| Net Profit YoY | 21.6% | -3093.9% |
| EPS (diluted) | $0.92 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | $2.7B | $1.0B | ||
| Q2 25 | $2.2B | $1.1B | ||
| Q1 25 | $2.1B | $1.0B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $2.2B | $1.1B | ||
| Q2 24 | $1.7B | $1.1B | ||
| Q1 24 | $1.8B | $1.1B |
| Q4 25 | $253.0M | $-1.4B | ||
| Q3 25 | $641.0M | $7.5M | ||
| Q2 25 | $277.0M | $-8.4M | ||
| Q1 25 | $290.0M | $-6.4M | ||
| Q4 24 | $208.0M | $-44.4M | ||
| Q3 24 | $457.0M | $-21.0M | ||
| Q2 24 | $260.0M | $-108.4M | ||
| Q1 24 | $262.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 20.2% | -116.0% | ||
| Q3 25 | 30.6% | 7.0% | ||
| Q2 25 | 18.5% | 4.3% | ||
| Q1 25 | 20.5% | 4.5% | ||
| Q4 24 | 10.2% | 10.0% | ||
| Q3 24 | 27.0% | 7.4% | ||
| Q2 24 | 21.3% | -2.5% | ||
| Q1 24 | 20.4% | -5.1% |
| Q4 25 | 14.2% | -127.8% | ||
| Q3 25 | 23.7% | 0.7% | ||
| Q2 25 | 12.5% | -0.8% | ||
| Q1 25 | 13.8% | -0.6% | ||
| Q4 24 | 10.7% | -3.9% | ||
| Q3 24 | 21.0% | -1.9% | ||
| Q2 24 | 15.4% | -10.2% | ||
| Q1 24 | 14.4% | 0.2% |
| Q4 25 | $0.92 | $-10.23 | ||
| Q3 25 | $2.35 | $0.05 | ||
| Q2 25 | $1.01 | $-0.06 | ||
| Q1 25 | $1.07 | $-0.05 | ||
| Q4 24 | $0.77 | $-0.32 | ||
| Q3 24 | $1.70 | $-0.15 | ||
| Q2 24 | $0.97 | $-0.79 | ||
| Q1 24 | $0.98 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.0M | — |
| Total DebtLower is stronger | $19.4B | — |
| Stockholders' EquityBook value | $13.4B | $2.9B |
| Total Assets | $48.5B | $8.5B |
| Debt / EquityLower = less leverage | 1.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.0M | — | ||
| Q3 25 | $9.0M | $432.1M | ||
| Q2 25 | $11.0M | $454.2M | ||
| Q1 25 | $23.0M | $409.9M | ||
| Q4 24 | $7.0M | $558.8M | ||
| Q3 24 | $17.0M | $1.5B | ||
| Q2 24 | $19.0M | $542.8M | ||
| Q1 24 | $85.0M | $658.5M |
| Q4 25 | $19.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $13.4B | $2.9B | ||
| Q3 25 | $12.8B | $4.4B | ||
| Q2 25 | $12.3B | $4.5B | ||
| Q1 25 | $12.2B | $4.4B | ||
| Q4 24 | $12.1B | $4.3B | ||
| Q3 24 | $11.8B | $4.6B | ||
| Q2 24 | $11.5B | $4.5B | ||
| Q1 24 | $11.4B | $4.7B |
| Q4 25 | $48.5B | $8.5B | ||
| Q3 25 | $47.4B | $10.1B | ||
| Q2 25 | $46.6B | $10.1B | ||
| Q1 25 | $45.7B | $9.8B | ||
| Q4 24 | $44.6B | $9.6B | ||
| Q3 24 | $43.3B | $11.2B | ||
| Q2 24 | $42.3B | $10.4B | ||
| Q1 24 | $41.3B | $10.6B |
| Q4 25 | 1.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $956.0M | $175.4M |
| Free Cash FlowOCF − Capex | $-54.0M | $148.6M |
| FCF MarginFCF / Revenue | -3.0% | 13.4% |
| Capex IntensityCapex / Revenue | 56.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 3.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-775.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $956.0M | $175.4M | ||
| Q3 25 | $1.1B | $51.7M | ||
| Q2 25 | $862.0M | $75.9M | ||
| Q1 25 | $431.0M | $-64.5M | ||
| Q4 24 | $817.0M | $312.6M | ||
| Q3 24 | $897.0M | $42.2M | ||
| Q2 24 | $557.0M | $9.5M | ||
| Q1 24 | $492.0M | $-1.4M |
| Q4 25 | $-54.0M | $148.6M | ||
| Q3 25 | $116.0M | $29.8M | ||
| Q2 25 | $-204.0M | $56.7M | ||
| Q1 25 | $-633.0M | $-90.0M | ||
| Q4 24 | $-473.0M | $274.9M | ||
| Q3 24 | $-240.0M | $15.1M | ||
| Q2 24 | $-445.0M | $-18.9M | ||
| Q1 24 | $-398.0M | $-26.5M |
| Q4 25 | -3.0% | 13.4% | ||
| Q3 25 | 4.3% | 2.9% | ||
| Q2 25 | -9.2% | 5.4% | ||
| Q1 25 | -30.2% | -8.6% | ||
| Q4 24 | -24.4% | 24.2% | ||
| Q3 24 | -11.0% | 1.4% | ||
| Q2 24 | -26.3% | -1.8% | ||
| Q1 24 | -21.9% | -2.4% |
| Q4 25 | 56.7% | 2.4% | ||
| Q3 25 | 36.6% | 2.1% | ||
| Q2 25 | 48.0% | 1.8% | ||
| Q1 25 | 50.7% | 2.4% | ||
| Q4 24 | 66.5% | 3.3% | ||
| Q3 24 | 52.3% | 2.5% | ||
| Q2 24 | 59.2% | 2.7% | ||
| Q1 24 | 49.0% | 2.3% |
| Q4 25 | 3.78× | — | ||
| Q3 25 | 1.72× | 6.89× | ||
| Q2 25 | 3.11× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 1.96× | — | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 1.88× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AEE
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
